- Price
- $104.67
- Day
- +6.52%
- Mkt Cap
- $12.66B
- 52W Range
- $84.70 – $128.90
- Volume
- 5.24M
- Beta
- 0.53
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
Delivers Q4 results in line with expectations while advancing strategic investments OAKLAND, Calif., Aug. 3, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) today reported results for the fourth quarter and fiscal year 2026, which ended June 30, 2026.
Read full article
Although the revenue and EPS for Clorox (CLX) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read full article
Clorox (CLX) came out with quarterly earnings of $1.66 per share, beating the Zacks Consensus Estimate of $1.64 per share. This compares to earnings of $2.87 per share a year ago.
Read full article
The company now expects sales to rise between 13% and 14% for the current fiscal year after its fourth-quarter revenue fell to $1.95 billion.
Read full article
Pine-Sol maker Clorox forecast annual sales above analysts' expectations on Monday, betting on improving demand for its health and wellness segments as well as from international customers despite macroeconomic uncertainty.
Read full article
Clorox NYSE: CLX said it is entering fiscal 2027 with improving market-share trends, a completed enterprise resource planning implementation and a plan to offset more than $200 million in expected supply-chain inflation through productivity initiatives and targeted pricing.
Read full article
The Clorox Company (NYSE:CLX) will release its fourth quarter earnings report after the closing bell on Monday, Aug. 3.
Read full article
The Clorox Company (CLX) Q4 2026 Earnings Call Transcript
Read full article
OAKLAND, Calif., July 31, 2026 /PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today that its board of directors has declared an increase to its quarterly dividend from $1.24 to $1.25 per share on the company's common stock.
Read full article
CLX Q4'26 results are expected to reflect y/y sales and earnings declines on ERP disruptions, cost inflation and sluggish category recoveries.
Read full article
First Trust Advisors LP trimmed its stake in shares of The Clorox Company (NYSE: CLX) by 15.5% during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 328,132 shares of the company's stock after selling 60,066 shares during
Read full article
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Read full article